Compass Therapeutics (CMPX) Profit After Tax (2018 - 2026)
Compass Therapeutics (CMPX) posted Profit After Tax of -$18.3 million for Q1 2026, down 16.59% sequentially from -$15.7 million in Q4 2025, and down 10.12% YoY from -$20.4 million in Q1 2025.
Compass Therapeutics (CMPX) Profit After Tax (2018 - 2026) Analysis & Trends
Compass Therapeutics has reported Profit After Tax for 9 years, with the latest figure at -$18.3 million in Q1 2026.
- Quarterly Profit After Tax fell 10.12% year-over-year to -$18.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$68.1 million (down 23.61% YoY) and the FY2025 annual result came in at -$66.4 million, down 34.52% from the prior year.
- Profit After Tax slipped to -$18.3 million in Q1 2026 per CMPX's latest filing, from -$15.7 million in the prior quarter.
- Over five years, Profit After Tax peaked at -$7.2 million in Q1 2022 and troughed at -$19.9 million in Q2 2025.
- A 5-year average of -$12.7 million and a median of -$12.1 million in 2022 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2022 and 2023: Profit After Tax sank 102.58% in 2022, then advanced 18.32% in 2023.
- Over 5 years, Profit After Tax stood at -$11.6 million in 2022, then declined by 12.78% to -$13.1 million in 2023, then slipped by 18.4% to -$15.5 million in 2024, then retreated by 1.47% to -$15.7 million in 2025, then dropped by 16.59% to -$18.3 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered -$18.3 million, -$15.7 million, and -$14.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 472.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 237.01 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,087.27 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 164.49 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.62 Mn |
| 10 | Compass Therapeutics | 405.20 Mn | 405.20 Mn | - | -25.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -25.25 Mn |
| Mar 31, 2026 | -18.32 Mn |
| Dec 31, 2025 | -15.71 Mn |
| Sep 30, 2025 | -14.19 Mn |
| Jun 30, 2025 | -19.88 Mn |
| Mar 31, 2025 | -16.63 Mn |
| Dec 31, 2024 | -15.48 Mn |
| Sep 30, 2024 | -9.90 Mn |
| Jun 30, 2024 | -13.08 Mn |
| Mar 31, 2024 | -10.79 Mn |
| Dec 31, 2023 | -13.08 Mn |
| Sep 30, 2023 | -9.89 Mn |
| Jun 30, 2023 | -11.28 Mn |
| Mar 31, 2023 | -7.84 Mn |
| Dec 31, 2022 | -11.59 Mn |
| Sep 30, 2022 | -12.10 Mn |
| Jun 30, 2022 | -8.49 Mn |
| Mar 31, 2022 | -7.16 Mn |
| Dec 31, 2021 | -12.98 Mn |
| Sep 30, 2021 | -5.98 Mn |